AVIEW LCS vs RX-1 Rhythm Express Remote Cardiac Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AVIEW LCS

by Coreline Soft

RX-1 Rhythm Express Remote Cardiac Monitoring System

by VivaQuant, Inc.

AI Verdict

Tool A, AVIEW LCS, is an AI-powered solution for analyzing CT scans to detect lung nodules, COPD, and assess coronary artery calcification, focusing on imaging-based structural and risk assessment. In contrast, Tool B, RX-1 Rhythm Express, is a wearable ECG monitoring system that uses AI for real-time arrhythmia detection, addressing cardiac rhythm abnormalities. While both tools incorporate AI in cardiology, they serve distinct diagnostic purposes and utilize different data modalities.

Choose AVIEW LCS if…

Choose AVIEW LCS if your primary need is a comprehensive, AI-powered solution for analyzing lung CT scans. This tool is ideal for clinics and hospitals focused on early lung cancer detection, detailed assessment of COPD, and coronary artery calcification scoring from a single low-dose CT, streamlining radiology workflows and enhancing diagnostic accuracy.

View AVIEW LCS →

Choose RX-1 Rhythm Express Remote Cardiac Monitoring System if…

Choose RX-1 Rhythm Express if you require a flexible and continuous remote cardiac monitoring solution for patients in an outpatient setting. This wearable patch system is best suited for detecting and monitoring various arrhythmias over extended periods using MCT, Event, or Holter modes, providing near real-time data transmission for timely physician review and improved patient comfort.

View RX-1 Rhythm Express Remote Cardiac Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AVIEW LCS	RX-1 Rhythm Express Remote Cardiac Monitoring System
Pricing	Subscription or one-off payment	Available
Deployment	Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)	Cloud-based
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools prioritize usability for their respective target audiences. AVIEW LCS streamlines complex diagnostic tasks for radiologists through automated analysis and PACS/RIS integration. RX-1 Rhythm Express offers a comfortable, easy-to-wear device for patients and an accessible cloud platform for clinicians to review data.

Clinical Value

AVIEW LCS

AVIEW LCS offers a comprehensive, multi-faceted assessment from a single CT scan, covering lung cancer, COPD, and coronary artery calcification, which can lead to more holistic and efficient diagnostic pathways. While RX-1 Rhythm Express provides crucial, high-quality continuous ECG data for arrhythmia detection, AVIEW LCS's integrated approach to multiple critical conditions from one scan provides a broader clinical impact.

Pricing & Value

RX-1 Rhythm Express Remote Cardiac Monitoring System

RX-1 Rhythm Express provides transparent and flexible pricing models, including subscription, fee-for-service, and split-bill options, allowing clinics to choose the best fit for their financial structure. AVIEW LCS requires direct contact for pricing, making it difficult to assess its value proposition without further engagement.

Enterprise Readiness

AVIEW LCS

AVIEW LCS offers a wider range of deployment options, including cloud, hybrid, local hardware, and virtualized solutions, catering to diverse enterprise IT infrastructures and security policies. Its explicit integration with PACS/RIS and third-party platforms ensures seamless workflow integration within existing hospital or radiology group systems.

Innovation

RX-1 Rhythm Express Remote Cardiac Monitoring System

RX-1 Rhythm Express's proprietary Multi-Domain Signal Processing (MDSPu2122) technology for superior noise suppression in a wearable ECG monitor, combined with AI for arrhythmia detection and near real-time data transmission, represents a significant technological breakthrough for improving data quality in remote cardiac monitoring. While AVIEW LCS is innovative in its multi-modal CT analysis, RX-1's core technology addresses a fundamental challenge in its domain.

Support & Docs

Tie

Both companies appear to offer standard support channels, including contact information and FAQs on their websites. However, neither provides detailed information regarding the extent, quality, or specific types of documentation and support services available, making it impossible to distinguish between them.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AVIEW LCS	RX-1 Rhythm Express Remote Cardiac Monitoring System
Name	AVIEW LCS	RX-1 Rhythm Express Remote Cardiac Monitoring System
Company	Coreline Soft Co.	VivaQuant
Tagline	AI-Powered Lung Cancer Screening & Cardiopulmonary Assessment	Next-Level Remote Cardiac Monitoring for Enhanced Diagnostics and Patient Comfort.
Primary Function	AI-powered solution for the detection and analysis of lung nodules, COPD, and coronary artery calcification from CT scans.	FDA-cleared, patch-style wearable device offering continuous ECG monitoring in MCT, Event, and Holter modes.
Categories	Cardiology AI, Oncology AI, Radiology & Imaging AI	Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties	Cardiology, Oncology, Pulmonology, Radiology	Cardiology
Key Features (Selection)	Automated lung nodule detection and analysis, Lung-RADS classification and reporting, Coronary Artery Calcification (CAC) scoring	Proprietary Multi-Domain Signal Processing (MDSP™) technology for noise suppression, AI-enabled advanced signal processing for arrhythmia detection, Continuous 2-channel ECG monitoring

Videos

Demos, reviews, and walkthroughs featuring AVIEW LCS and RX-1 Rhythm Express Remote Cardiac Monitoring System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of AVIEW LCS and RX-1 Rhythm Express?

AVIEW LCS is an AI-powered solution for the detection and analysis of lung nodules, lung cancer screening, COPD, and coronary artery calcification from low-dose CT scans. RX-1 Rhythm Express is a remote cardiac monitoring system providing continuous ECG monitoring in MCT, Event, and Holter modes for arrhythmia detection.

How do the data acquisition and patient interaction models differ between these two tools?

AVIEW LCS processes data from existing low-dose CT scans, requiring patients to undergo a CT imaging procedure. RX-1 Rhythm Express is a wearable patch device that continuously monitors a patient's ECG remotely and transmits data to a cloud platform.

What specific AI-powered diagnostic capabilities does each tool offer?

AVIEW LCS offers AI for automated lung nodule detection and analysis, Lung-RADS classification, nodule volume quantification, emphysema quantification, and coronary artery calcification scoring. RX-1 Rhythm Express utilizes AI-enabled advanced signal processing for accurate arrhythmia detection and proprietary MDSPu2122 technology for superior noise suppression.

What specialties are primarily targeted by AVIEW LCS versus RX-1 Rhythm Express?

AVIEW LCS is designed for specialties such as Cardiology, Oncology, Pulmonology, and Radiology, given its focus on lung cancer screening and cardiopulmonary assessment. RX-1 Rhythm Express is specifically targeted towards Cardiology for remote cardiac monitoring and arrhythmia detection.